Product Images Levalbuterol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Levalbuterol NDC 65862-942 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - levalbuterol fig1
This text represents a figure showing the mean percent change from baseline forced expiratory volume (FEV) on day 1 for adults and adolescents greater than 12 years old. The figure compares the effects of different treatments on FEV. The treatments displayed are Lev1.25, Lev0.63, Rac25, and PBO. The text shows a graph with the percent change in FEV on the y-axis and time in hours on the x-axis. The text provides information on the number of participants (n) for each treatment displayed on the graph.*
Figure F - levalbuterol fig10
Figure G.1, G.2 - levalbuterol fig11
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1.25 mg/0.5 mL - Pouch Label - levalbuterol fig12
This is a prescription inhalation solution in a 0.5 ml sterile vial that contains 125mg of Levalbuterol. It is a concentrate and should be diluted before use. It is prescribed by physicians and should not be exceeded from the recommended dose. The solution contains no preservatives and should be protected from light. It should be kept at temperature between 20-25°C. The package should be discarded if the solution is not colorless. The product is distributed by Aurobindo Pharma USA.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1.25 mg/0.5 mL - Container-Carton - levalbuterol fig13
This is a description of Levalbuterol, which is an inhalation solution medication used to treat asthma and other respiratory conditions. It is distributed by Aurobindo Pharma USA, Inc. Each 0.5 mL unit-dose vial contains 1.25 mg of levalbuterol hydrochloride in an aqueous solution containing sodium, sodium citrate dihydrate, sodium chloride, and hydrochloric acid. The solution is intended for oral inhalation only and must be diluted before use. It is available in sterile unit-dose vials and must be protected from light and stored at a controlled room temperature. This medication is only to be used as directed by a physician and should be discarded if the solution is not colorless.*
Figure 2 - levalbuterol fig2
This text provides data on the mean percent change in Forced Expiratory Volume (FEV) from baseline for adults and adolescents over the age of 12 on Day 29. The data is presented in a graph with four different treatment groups: Lev1.25, Lev 063, Rac 25, and PBO (placebo), with the number of participants in each group. The mean change in FEV is shown to be 15% and the graph also includes a time scale in hours.*
Figure 3 - levalbuterol fig3
The given text appears to be a statistical analysis of Mean Percent Change from Baseline FEV (Forced Expiratory Volume) in children aged 6 to 11 years on Day 1. It includes the comparison of different treatments (Lev0.63, Lev0.31, Rac 2.5, Rac 1.25, and Pbo) and their impact on FEV. Figure 3 displays the comparison results. Time (hours) is also mentioned on the X-axis of the graph.*
Figure 4 - levalbuterol fig4
Figure A - levalbuterol fig5
Figure B - levalbuterol fig6
Figure C - levalbuterol fig7
Figure D - levalbuterol fig8
Figure E.1, E.2 - levalbuterol fig9
This is a product called "mouthpiece face mask". Two figures (E.1 and E.2) are shown, which may presumably depict the product from different angles. No further information or context is available.*
Chemical Structure - levalbuterol str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.